研究文章
胃癌伴类白细胞反应：一例罕见病例报告及文献综述
摘要
关键词
参考
Sakka V, Tsiodras S, Giamarellos-Bourboulis EJ, Giamarellou H: An update on the etiology and diagnostic evaluation of a leukemoid reaction. Eur J Intern Med 2006, 17(6):394-398.
Abukhiran I, Mott SL, Bellizzi AM , et al.: Paraneoplastic leukemoid reaction: Case report and review of the literature. Pathol Res Pract 2021, 217:153295.
Qing L, Xiang T, Guofu Z , et al: Leukemoid reaction in cervical cancer: a case report and review of the literature. BMC Cancer 2014, 14:670.
Hoshimoto S, Hoshi N, Ozawa I, et al.: Rapid progression of a granulocyte colony-stimulating factor-producing liver tumor metastasized from esophagogastric junction cancer: A case report and literature review. Oncol Lett 2018, 15(5):6475-6480.
Moro K, Nagahashi M, Naito T, et al.: Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor: a case of a rare malignancy. Surg Case Rep 2017, 3(1):67.
Mukhopadhyay S, Mukhopadhyay S, Banki K, et al: Leukemoid reaction: a diagnostic clue in metastatic carcinoma mimicking classic Hodgkin lymphoma. Arch Pathol Lab Med 2004, 128(12):1445-1447.
Xiang YY, Deng CC, Liu HY,et al: The Prognostic Effect of Multidisciplinary Team Intervention in Patients with Advanced Gastric Cancer. Curr Oncol 2022, 29(2):1201-1212.
Demers M, Krause DS, Schatzberg D, et al: Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci U S A 2012, 109(32):13076-13081.
Pezzella M, Quintarelli C, Quadraccia MC, et al: Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells. J Hematol Oncol 2024, 17(1):127.
He K, Liu X, Hoffman RD, et al: G-CSF/GM-CSF-induced hematopoietic dysregulation in the progression of solid tumors. FEBS Open Bio 2022, 12(7):1268-1285.
Abukhiran IA, Jasser J, Syrbu S: Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours. J Clin Pathol 2020, 73(6):310-313.
Karagiannidis I, Salataj E, Said Abu Egal E,et al: G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation. Cytokine 2021, 142:155479.
Azzam O, Hewavitharana CH, Fermoyle S, et al: Paraneoplastic leukemoid reaction in a localised squamous cell oesophageal cancer with paracrine G-CSF production. BMJ Case Rep 2020, 13(10).
Zhou C, Wang B, Teng C, et al: A phase Ia study of a novel anti-HER2 antibody-drug conjugate GQ1001 in patients with previously treated HER2 positive advanced solid tumors. J Transl Med 2025, 23(1):37.
Gravalos C, Jimeno A: HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008, 19(9):1523-1529.
Bang YJ, Van Cutsem E, Feyereislova A, et al: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010, 376(9742):687-697.
Erdem O, Canbak T, Bacaksiz ME,et al: Trastuzumab significantly improves survival in resectable HER-2 positive gastric cancer: A retrospective study. Turk J Surg 2025, 41(1):85-91.
